Phase I/II trial of vorinostat combined with temozolomide (TMZ) and radiation therapy (RT) for newly diagnosed glioblastoma (GBM) (N0874-ABTC0902, Alliance): Final results of the phase I trial.
Evanthia Galanis
No relevant relationships to disclose
Jann Nagina Sarkaria
No relevant relationships to disclose
S. Keith Anderson
No relevant relationships to disclose
Wenting Wu
No relevant relationships to disclose
Kurt A. Jaeckle
No relevant relationships to disclose
Caterina Giannini
No relevant relationships to disclose
Jan C. Buckner
No relevant relationships to disclose
Patrick Y. Wen
Honoraria - Merck
Research Funding - Merck